VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $10,000 | +11.1% | 68 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $9,000 | -35.7% | 68 | -37.0% | 0.00% | -40.0% |
| Q2 2014 | $14,000 | -50.0% | 108 | -49.1% | 0.01% | 0.0% |
| Q1 2014 | $28,000 | +55.6% | 212 | +36.8% | 0.01% | -28.6% |
| Q4 2013 | $18,000 | -5.3% | 155 | -14.4% | 0.01% | -30.0% |
| Q3 2013 | $19,000 | +216.7% | 181 | +141.3% | 0.01% | +150.0% |
| Q2 2013 | $6,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |